Stockscreener 앱 받기
36.60
1.03%
-0.38
Terns Pharmaceuticals Inc 주식(TERN)의 최신 뉴스
Wall Street forecasts 42.31% upside to Terns Pharmaceuticals, Inc. (TERN) - MSN
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN) - Yahoo Finance
Terns Pharmaceuticals stock jumps 10% as JPM conference puts TERN-701 back on the map - TechStock²
Terns Pharmaceuticals (NASDAQ:TERN) Trading Up 10.4%Should You Buy? - MarketBeat
Aug Patterns: Can Terns Pharmaceuticals Inc stock sustain institutional interestJuly 2025 Final Week & Consistent Profit Trade Alerts - Bộ Nội Vụ
J.P. Morgan: Terns Looks To Take Flight With TERN-701 In 2026 - Citeline News & Insights
William Blair reiterates Outperform rating on Terns Pharmaceuticals stock By Investing.com - Investing.com Canada
Terns Pharmaceuticals (TERN) Valuation After Encouraging TERN 701 CML Data And Capital Raise Powered Development Plans - Yahoo Finance
Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN) - Insider Monkey
Terns Pharmaceuticals (NASDAQ:TERN) Trading Down 6.3%Here's Why - MarketBeat
Assessing Terns Pharmaceuticals (TERN) Valuation After Recent Share Price Swings And Elevated Price To Book Ratio - Sahm
Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Terns Pharmaceuticals (TERN) - The Globe and Mail
How Rhythm Pharmaceuticals, Inc. stock performs during market volatility - Улправда
Tern Pharmaceuticals (TERN) soars 630% on CML treatment best-in-class potential - MSN
Terns Pharmaceuticals (TERN) price target increased by 75.91% to 54.63 - MSN
Why Terns Pharmaceuticals Inc. stock could see breakout soonEarnings Beat & Consistent Return Investment Signals - ulpravda.ru
Why Terns Pharmaceuticals Inc. stock could be next big winnerEarnings Recap Summary & Daily Entry Point Trade Alerts - Улправда
Will Fast Track TERN-701 Status and $747.5 Million Raise Change Terns Pharmaceuticals' (TERN) Narrative - Sahm
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Star Tribune - FinancialContent
Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock By Investing.com - Investing.com Australia
Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock - Investing.com
Terns Pharmaceuticals CEO Burroughs sells $2.7m in shares By Investing.com - Investing.com South Africa
Terns Pharmaceuticals CEO Burroughs sells $2.7m in shares - Investing.com
Insider Selling: Terns Pharmaceuticals (NASDAQ:TERN) Insider Sells 1,155 Shares of Stock - MarketBeat
With 53% Institutional Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Is a Favorite Amongst the Big Guns - 富途牛牛
Terns Pharmaceuticals reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential - Insider Monkey
Two new Terns hires receive 10-year stock options as hiring incentive - Stock Titan
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
Terns Pharmaceuticals Earnings Notes - Trefis
The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals
12 Overlooked Stocks That Delivered Massive Gains In 2025 - RTTNews
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale - ts2.tech
Exchange Traded Concepts LLC Has $912,000 Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Terns Pharmaceuticals stock soars after leukemia drug delivers big early responses in tough-to-treat patients - MSN
Pharmaceutical Stocks To Follow TodayDecember 10th - MarketBeat
Terns Pharmaceuticals proposes $400M equity offering - MSN
Terns Pharmaceuticals (TERN) climbs 53% on stellar leukemia treatment trial - MSN
Truist Securities maintains Terns Pharmaceuticals (TERN) buy recommendation - MSN
Terns Pharmaceuticals (TERN) Is Down 7.7% After Strong TERN-701 Phase 1 DataHas The Bull Case Changed? - Sahm
Jim Cramer highlights massive gains for Terns Pharmaceuticals shareholders - MSN
Terns Pharmaceuticals (TERN) Price Target Increased by 75.91% to 54.63 - Nasdaq
Will Terns Pharmaceuticals Inc. stock gain from government policies2025 Bull vs Bear & Weekly High Potential Alerts - moha.gov.vn
How Terns Pharmaceuticals Inc. stock performs in weak economyEarnings Performance Report & High Conviction Trade Alerts - Улправда
Is Terns Pharmaceuticals Inc. stock attractive for long term wealth buildingJobs Report & Target Return Focused Stock Picks - Улправда
Jim Cramer Highlights Massive Gains for Terns Pharmaceuticals Shareholders - Finviz
Terns Pharmaceuticals unveils promising phase 1 trial data - MSN
4.73%
0.92%
자본화:
|
볼륨(24시간):